Annual CFF
$30.19 M
+$30.64 M+6899.77%
31 December 2023
Summary:
Longboard Pharmaceuticals annual cash flow from financing activities is currently $30.19 million, with the most recent change of +$30.64 million (+6899.77%) on 31 December 2023. During the last 3 years, it has fallen by -$28.57 million (-48.62%). LBPH annual CFF is now -60.51% below its all-time high of $76.45 million, reached on 31 December 2021.LBPH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$560.00 K
+$539.00 K+2566.67%
30 September 2024
Summary:
Longboard Pharmaceuticals quarterly cash flow from financing activities is currently $560.00 thousand, with the most recent change of +$539.00 thousand (+2566.67%) on 30 September 2024. Over the past year, it has dropped by -$5.39 million (-90.58%). LBPH quarterly CFF is now -99.80% below its all-time high of $286.40 million, reached on 31 March 2024.LBPH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$290.00 M
-$5.39 M-1.82%
30 September 2024
Summary:
Longboard Pharmaceuticals TTM cash flow from financing activities is currently $290.00 million, with the most recent change of -$5.39 million (-1.82%) on 30 September 2024. Over the past year, it has increased by +$263.26 million (+984.62%). LBPH TTM CFF is now -1.82% below its all-time high of $295.38 million, reached on 30 June 2024.LBPH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LBPH Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6899.8% | -90.6% | +984.6% |
| 3 y3 years | -48.6% | +10000.0% | +118.0% |
| 5 y5 years | - | - | - |
LBPH Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -60.5% | +6899.8% | -99.8% | +226.1% | -1.8% | >+9999.0% |
| 5 y | 5 years | -60.5% | +6899.8% | -99.8% | +226.1% | -1.8% | >+9999.0% |
| alltime | all time | -60.5% | +6899.8% | -99.8% | +226.1% | -1.8% | >+9999.0% |
Longboard Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $560.00 K(+2566.7%) | $290.00 M(-1.8%) |
| June 2024 | - | $21.00 K(-100.0%) | $295.38 M(+0.0%) |
| Mar 2024 | - | $286.40 M(+9415.1%) | $295.24 M(+877.9%) |
| Dec 2023 | $30.19 M(-6899.8%) | $3.01 M(-49.4%) | $30.19 M(+12.9%) |
| Sept 2023 | - | $5.95 M(-4856.8%) | $26.74 M(+28.6%) |
| June 2023 | - | -$125.00 K(-100.6%) | $20.79 M(-0.6%) |
| Mar 2023 | - | $21.36 M(-4910.8%) | $20.92 M(-4810.8%) |
| Dec 2022 | -$444.00 K | -$444.00 K(<-9900.0%) | -$444.00 K(<-9900.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $0.00(0.0%) | -$2000.00(-100.1%) |
| Mar 2022 | - | $0.00(0.0%) | $3.17 M(-95.9%) |
| Dec 2021 | $76.45 M(+30.1%) | $0.00(-100.0%) | $76.45 M(-42.5%) |
| Sept 2021 | - | -$2000.00(-100.1%) | $133.01 M(-0.7%) |
| June 2021 | - | $3.17 M(-95.7%) | $133.94 M(+1.5%) |
| Mar 2021 | - | $73.28 M(+29.6%) | $132.00 M(+124.7%) |
| Dec 2020 | $58.76 M | $56.56 M(+6021.0%) | $58.76 M(+2570.8%) |
| Sept 2020 | - | $924.00 K(-25.3%) | $2.20 M(+72.4%) |
| June 2020 | - | $1.24 M(+3071.8%) | $1.28 M(+3171.8%) |
| Mar 2020 | - | $39.00 K | $39.00 K |
FAQ
- What is Longboard Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals annual CFF year-on-year change?
- What is Longboard Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals quarterly CFF year-on-year change?
- What is Longboard Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals TTM CFF year-on-year change?
What is Longboard Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of LBPH is $30.19 M
What is the all time high annual CFF for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high annual cash flow from financing activities is $76.45 M
What is Longboard Pharmaceuticals annual CFF year-on-year change?
Over the past year, LBPH annual cash flow from financing activities has changed by +$30.64 M (+6899.77%)
What is Longboard Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of LBPH is $560.00 K
What is the all time high quarterly CFF for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high quarterly cash flow from financing activities is $286.40 M
What is Longboard Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, LBPH quarterly cash flow from financing activities has changed by -$5.39 M (-90.58%)
What is Longboard Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of LBPH is $290.00 M
What is the all time high TTM CFF for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high TTM cash flow from financing activities is $295.38 M
What is Longboard Pharmaceuticals TTM CFF year-on-year change?
Over the past year, LBPH TTM cash flow from financing activities has changed by +$263.26 M (+984.62%)